SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | – | 4,000 | +100.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 2,000 | -20.0% | 0.00% | – |
| Q4 2015 | $1,000 | -95.5% | 2,500 | -80.6% | 0.00% | – |
| Q3 2015 | $22,000 | -52.2% | 12,911 | -37.8% | 0.00% | – |
| Q2 2015 | $46,000 | -51.1% | 20,766 | -57.3% | 0.00% | – |
| Q1 2015 | $94,000 | -18.3% | 48,603 | +12.2% | 0.00% | – |
| Q4 2014 | $115,000 | -48.4% | 43,319 | -41.6% | 0.00% | – |
| Q3 2014 | $223,000 | +443.9% | 74,181 | +641.8% | 0.00% | – |
| Q2 2014 | $41,000 | -21.2% | 10,000 | -16.7% | 0.00% | – |
| Q1 2014 | $52,000 | +160.0% | 12,000 | +287.0% | 0.00% | – |
| Q3 2013 | $20,000 | +33.3% | 3,101 | +3.4% | 0.00% | – |
| Q2 2013 | $15,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |